Nair Lopes

Summary

Affiliation: Institute of Molecular Pathology and Immunology
Country: Portugal

Publications

  1. pmc Vitamin D and the mammary gland: a review on its role in normal development and breast cancer
    Nair Lopes
    IPATIMUP Institute of Molecular Pathology and Immunology of the University of Porto, Rua Dr Roberto Frias, S N, 4200 465, Porto, Portugal
    Breast Cancer Res 14:211. 2012
  2. pmc Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
    Andre Albergaria
    Development Domain, Institute of Life and Health Sciences ICVS, School of Health Sciences of Minho University, Campus de Gualtar, Braga, Portugal
    Breast Cancer Res 11:R40. 2009
  3. pmc Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
    Nair Lopes
    Institute of Molecular Pathology and Immunology of the University of Porto, Porto 4200 465, Portugal
    BMC Cancer 10:483. 2010

Detail Information

Publications3

  1. pmc Vitamin D and the mammary gland: a review on its role in normal development and breast cancer
    Nair Lopes
    IPATIMUP Institute of Molecular Pathology and Immunology of the University of Porto, Rua Dr Roberto Frias, S N, 4200 465, Porto, Portugal
    Breast Cancer Res 14:211. 2012
    ..Accordingly, we review data on the influence of vitamin D in the development of normal breast and the expression of vitamin D-related proteins (VDR, CYP27B1 and CYP24A21) in benign mammary lesions and ductal carcinomas in situ...
  2. pmc Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
    Andre Albergaria
    Development Domain, Institute of Life and Health Sciences ICVS, School of Health Sciences of Minho University, Campus de Gualtar, Braga, Portugal
    Breast Cancer Res 11:R40. 2009
    ..The purpose of this study was to explore if the expression of FOXA1 and GATA-3 may provide an opportunity to stratify subsets of patients that could have better outcome, among the ERalpha-negative/poor prognosis breast cancer group...
  3. pmc Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
    Nair Lopes
    Institute of Molecular Pathology and Immunology of the University of Porto, Porto 4200 465, Portugal
    BMC Cancer 10:483. 2010
    ..We aimed to study the expression of these three proteins by immunohistochemistry in a series of breast lesions...